ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

7 links0 made here, not in the record8 judgments1 judge (our rules as one)0 record changes seen
Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04279847Safety and TolerabilityStudy of INCB057643 inParticipants WithMyelofibrosis and OtherAdvanced Myeloid NeoplasmsIncyte CorporationPhase 1 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSPrimary MyelofibrosisThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionMyelodysplastic SyndromesThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termMyeloproliferative DisordersThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Wider: a narrower term is filedWider: a narrower term is filedRecurrenceThe registry's MeSH filing›Nov 14 · Our condition-kind rule · General: a category, not a diseaseGeneral: a category, not a diseaseThrombocythemia, EssentialThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termDRUGSINCB057643Intervention entry›As of now · Our role rule · TestedTestedRuxolitinibIntervention entry›As of now · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Primary Myelofibrosis

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistryPrimary Myelofibrosis, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Nov 14Primary MyelofibrosisOur condition-kind ruleFinest filed termCurrent
Nov 14Myelodysplastic SyndromesOur condition-kind ruleFinest filed termCurrent
Nov 14Myeloproliferative DisordersOur condition-kind ruleWider: a narrower term is filedCurrent
Nov 14RecurrenceOur condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Thrombocythemia, EssentialOur condition-kind ruleFinest filed termCurrent
As of nowPrimary MyelofibrosisOur main-condition rule (R9)Main conditionCurrent
As of nowINCB057643Our role ruleTestedCurrent
As of nowRuxolitinibOur role ruleBackgroundCurrent